The Medicines and Healthcare products Regulatory Agency approves the country's first monoclonal antibody cocktail drug (Ronapreve) developed by Regeneron and Roche to treat severe COVID-19 patients in the United Kingdom. (Euronews) COVID-19 pandemic in the United Kingdom, COVID-19 drug developmentCOVID-19 pandemic in EuropeCOVID-19 pandemic link embed save